Does COVID-19 Related Lockdown Restrictions Impact People With Musculoskeletal Disorders? A Systematic Review

Francis Fatoye1,2, Clara Fatoye3, Joyceline Lawoe4

  • 1Department of Health Professions, Manchester Metropolitan University, Manchester, UK.

Musculoskeletal Care
|August 10, 2024
PubMed

Insights

Coronavirus disease 2019 (COVID-19) lockdowns worsened pain, injuries, and mental health for people with musculoskeletal disorders. This review highlights increased healthcare use and decreased quality of life during pandemic restrictions.

Area of Science:

  • Public Health
  • Rheumatology
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) lockdowns posed risks to individuals with musculoskeletal (MSK) disorders.
  • Physical and psychological disabilities were potential consequences for this vulnerable population.

Purpose of the Study:

  • To systematically review the impact of COVID-19 lockdown restrictions on individuals with MSK disorders.
  • To summarize evidence on physical and psychological effects during pandemic-related restrictions.

Main Methods:

  • A systematic literature search was conducted across six electronic databases up to June 10, 2024.
  • Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed for study selection and appraisal.
  • Narrative synthesis was used to summarize data from 15 included studies, with quality assessed using the Newcastle-Ottawa Scale.

Main Results:

  • Fifteen studies involving 40 to 1800 participants were analyzed.
  • Musculoskeletal disorder patients experienced increased pain, stress, depression, anxiety, and injuries during COVID-19 lockdowns.
  • A decrease in quality of life and increased emergency department visits were reported.

Conclusions:

  • This review is the first to document the negative effects of COVID-19 lockdowns on MSK patients.
  • Findings indicate heightened risks for pain, MSK injuries, and healthcare utilization, alongside reduced quality of life.
  • Results can inform future public health policies and management strategies for MSK disorders during pandemics.
Abstract